Literature DB >> 230034

A model for the chemical interactions of adenosine 3':5'-monophosphate with the R subunit of protein kinase type I. Refinement of the cyclic phosphate binding moiety of protein kinase type I.

B Jastorff, J Hoppe, M Morr.   

Abstract

The cAMP receptor site in the regulatory subunit of adenosine 3':5'-monophosphate (cAMP)-dependent protein kinase type I was mapped using analogues of cAMP in which the ribose phosphate moiety was systematically modified. Electronical alteration of the cyclophosphate ring at the 3' and 5' positions by sulfur and nitrogen decreased the affinity of these analogues towards the kinase. Substituents at these positions are not tolerated. Testing the separated diastereomers of derivatives in which one of the exocyclic oxygens at the phosphorus has been substituted by sulfur, it was found that one diastereoisomer is preferentially recognized. Based on these results it is proposed that the hydrophylic cyclic phosphate-ribose moiety of cAMP is bound to the kinase via its 3' and 5'-oxygens, the 2'-hydroxy group and the negative charge in a fixed position. Based on our and other published results it is further proposed, that the adenine moiety is bound in a hydrophobic cleft without any hydrogen bond interactions. The chemical interactions between cAMP and the R subunit of protein kinase type I differ from those found for the binding of cAMP to the chemoreceptor of Dictyostelium discoideum [18].

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 230034     DOI: 10.1111/j.1432-1033.1979.tb19750.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  8 in total

1.  Mapping of the epitope/paratope interactions of a monoclonal antibody directed against adenosine 3',5'-monophosphate.

Authors:  N Nass; C Colling; M Cramer; H G Genieser; E Butt; E Winkler; L Jaenicke; B Jastorff
Journal:  Biochem J       Date:  1992-07-01       Impact factor: 3.857

2.  Sporulation delay by stable cAMP analogues in the slime moldPhysarum polycephalum.

Authors:  Christine Brandt; Bernd Jastorff; Armin Hildebrandt
Journal:  Rouxs Arch Dev Biol       Date:  1986-05

3.  Fine-structure mapping of charge-shift mutations in regulatory subunit of type I cyclic AMP-dependent protein kinase.

Authors:  R A Steinberg
Journal:  Mol Cell Biol       Date:  1984-06       Impact factor: 4.272

Review 4.  Recent advances in the discovery of small molecules targeting exchange proteins directly activated by cAMP (EPAC).

Authors:  Haijun Chen; Christopher Wild; Xiaobin Zhou; Na Ye; Xiaodong Cheng; Jia Zhou
Journal:  J Med Chem       Date:  2013-11-27       Impact factor: 7.446

5.  Isoleucine 368 is involved in low-affinity binding of N6-modified cAMP analogues to site B of the regulatory subunit of cAMP-dependent protein kinase I.

Authors:  I Huq; W R Dostmann; D Ogreid
Journal:  Biochem J       Date:  1996-05-15       Impact factor: 3.857

Review 6.  Regulating the ubiquitin/proteasome pathway via cAMP-signaling: neuroprotective potential.

Authors:  He Huang; Hu Wang; Maria E Figueiredo-Pereira
Journal:  Cell Biochem Biophys       Date:  2013-09       Impact factor: 2.194

7.  Structure-activity relationship of cytoplasmic 5'-nucleotidase substrate sites.

Authors:  A C Skladanowski; C Hoffmann; J Krass; B Jastorff; W Makarewicz
Journal:  Biochem J       Date:  1996-03-15       Impact factor: 3.857

8.  Sites of phosphorylation and mutation in regulatory subunit of cyclic AMP-dependent protein kinase from S49 mouse lymphoma cells: mapping to structural domains.

Authors:  R A Steinberg
Journal:  J Cell Biol       Date:  1983-10       Impact factor: 10.539

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.